Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

Our S&P rating upgrade should cheapen loans and draw capital

Mint Chennai

|

August 20, 2025

It vindicates India's argument while easing private access to capital and enabling greater inflows

- MADAN SABNAVIS

The big three of the global credit rating business, Standard & Poor's (S&P), Moody's and Fitch, have a dominant market presence. While one could dispute their rationale behind a rating, the market accepts their assessments, which is what matters when any company is borrowing overseas. Therefore, while the Indian government does not borrow in the global market, since its debt is denominated in rupees, all Indian companies encounter the impact of a global rating as their own rating is benchmarked with that of the sovereign. While some corporations may have a higher rating of a notch or two, depending on their global business, the creditworthiness of most Indian companies is tied to the sovereign rating. Their cost of borrowing, thus, depends on how the world's big three rate the government as a debtor.

The government has been trying to convince these agencies that India deserves a much higher rating. The country's growth story has been one of the best in the world, both before and after Covid. Fiscal consolidation has been pursued in the best possible manner and the external account has been robust with low current account deficits and strong capital inflows. All this has been under a stable inflation environment. This is the context in which India's recent rating upgrade by S&P should be viewed.

Mint Chennai からのその他のストーリー

Mint Chennai

Mint Chennai

Donald Trump's influence trade uses power as a global currency

The US leader’s pursuit of hard bargains poses a challenge for India that needs to be countered with the best diplomatic tools

time to read

4 mins

January 26, 2026

Mint Chennai

ED charge-sheets gaming app WinZO

ED alleged players lost ₹734 crore on the platform has the firm manipulated the game's algorithms.

time to read

1 min

January 26, 2026

Mint Chennai

Mint Chennai

Self-reliance, swadeshi guide economic journey: President

Against a backdrop of geopolitical tensions and slowing global growth, President Droupadi Murmu on Sunday said India's economic momentum remains strong, underpinned by reforms, infrastructure investment and a renewed focus on self-reliance.

time to read

1 min

January 26, 2026

Mint Chennai

Can DLF reverse a pre-sales dip?

DLF

time to read

2 mins

January 26, 2026

Mint Chennai

EU leaders arrive in India ahead of summit

European Council president Antonio Costa arrived in India on Sunday as the European Union (EU) and New Delhi seek to seal a free trade pact, capping nearly two decades of negotiations between the economic behemoths.

time to read

1 min

January 26, 2026

Mint Chennai

Mint Chennai

India to display military might, growth story at R-Day parade

India will display its development journey, cultural diversity and military might, including newly-raised units and mock-ups of major weapon systems deployed during Operation Sindoor, at the 77th Republic Day celebrations on Monday.

time to read

1 min

January 26, 2026

Mint Chennai

CPCL Q3 net profit rises to ₹1,002 cr

Chennai Petroleum Corp. Ltd (CPCL) reported a consolidated profit of ₹1,001.59 crore for the October-December 2025 quarter, driven by sustained operational excellence, the company said.

time to read

1 min

January 26, 2026

Mint Chennai

Fast chargers surge, but there's way to go

The availability of fast chargers along India's major highways surged last year as the government and companies ramped up charging infrastructure amid growing electric vehicle (EV) penetration in the country.

time to read

1 min

January 26, 2026

Mint Chennai

CELEBRATING A LEGACY OF SHARED DIFFERENCES

Why do we celebrate 26 January?

time to read

3 mins

January 26, 2026

Mint Chennai

Mint Chennai

How viral fears prevented a polio vax trial in India

A fear of Chinese polio sneaking in has forced the apex drug regulator to slam the door on human trials of a paediatric vaccine, as it fights to preserve India's hard-won status as a polio-free nation.

time to read

1 min

January 26, 2026

Listen

Translate

Share

-
+

Change font size